drugset / Trial / NCT03038321

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

NCT03038321

Phase 4 Unknown 150 enrolled Mansoura University
RandomizedParallel-groupSingle-blindTreatment

Summary

Compare the different supposed clinical treatment of side effects associated with intravesical BCG by levofloxacin (quinolones) vs solifenacin (selective anti-muscarinic) vs lornoxicam (NSAID)

Timeline

Start
2017-02-01
Primary completion
2017-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levofloxacin Small molecule 500 mg
Comparator Lornoxicam Small molecule 8 mg
Comparator Solifenacin Small molecule 10 mg